{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancers", "cell signaling pathways", "clinical trials", "resveratrol", "synergistic effect"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35566016", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "17"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "21"}], "Language": ["eng"], "ELocationID": ["2665", "10.3390/molecules27092665"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "21"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer.", "Abstract": {"AbstractText": ["Cancer is among the most prominent causes of mortality worldwide. Different cancer therapy modes employed, including chemotherapy and radiotherapy, have been reported to be significant in cancer management, but the side effects associated with these treatment strategies are still a health problem. Therefore, alternative anticancer drugs based on medicinal plants or their active compounds have been generating attention because of their less serious side effects. Medicinal plants are an excellent source of phytochemicals that have been recognized to have health-prompting effects through modulating cell signaling pathways. Resveratrol is a well-known polyphenolic molecule with antioxidant, anti-inflammatory, and health-prompting effects among which its anticancer role has been best defined. Additionally, this polyphenol has confirmed its role in cancer management because it activates tumor suppressor genes, suppresses cell proliferation, induces apoptosis, inhibits angiogenesis, and modulates several other cell signaling molecules. The anticancer potential of resveratrol is recognized in numerous in vivo and in vitro studies. Previous experimental data suggested that resveratrol may be valuable in cancer management or improve the efficacy of drugs when given with anticancer drugs. This review emphasizes the potential role of resveratrol as an anticancer drug by modulating numerous cells signaling pathways in different types of cancer."]}, "AuthorList": [{"Identifier": ["0000-0002-5260-0265"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Almatroodi", "ForeName": "Saleh A", "Initials": "SA"}, {"Identifier": ["0000-0001-9357-2216"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "A Alsahli", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "S M Aljohani", "ForeName": "Abdullah", "Initials": "A"}, {"Identifier": ["0000-0002-0151-8309"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Alhumaydhi", "ForeName": "Fahad A", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Babiker", "ForeName": "Ali Yousif", "Initials": "AY"}, {"Identifier": ["0000-0001-6030-4493"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Amjad Ali", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Rahmani", "ForeName": "Arshad Husain", "Initials": "AH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Polyphenols"}, {"RegistryNumber": "Q369O8926L", "NameOfSubstance": "Resveratrol"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Polyphenols"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Resveratrol"}], "CoiStatement": "All authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Figueir\u00f3 F., Bernardi A., Frozza R.L., Terroso T., Zanotto-Filho A., Jandrey E.H., Moreira J.C.F., Salbego C.G., Edelweiss M.I., Pohlmann A.R. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J. Biomed. Nanotechnol. 2013;9:516\u2013526. doi: 10.1166/jbn.2013.1547.", "ArticleIdList": ["10.1166/jbn.2013.1547", "23621009"]}, {"Citation": "Hu Z., Liang W., Yang Y. Personalized estimate of chemotherapy-induced nausea and vomiting: Development and external validation of a nomogram in cancer patients receiving highly/moderately emetogenic chemotherapy. Medicine. 2016;95:e2476. doi: 10.1097/MD.0000000000002476.", "ArticleIdList": ["10.1097/MD.0000000000002476", "PMC4718276", "26765450"]}, {"Citation": "Chung V.C., Wu X., Lu P. Chinese herbal medicine for symptom management in cancer palliative care: Systematic review and meta-analysis. Medicine. 2016;95:e2793. doi: 10.1097/MD.0000000000002793.", "ArticleIdList": ["10.1097/MD.0000000000002793", "PMC4998628", "26886628"]}, {"Citation": "Chedea V.S., Vicas S.I., Sticozzi C., Pessina F., Frosini M., Maioli E., Valacchi G. Resveratrol: From diet to topical usage. Food Funct. 2017;8:3879\u20133892. doi: 10.1039/C7FO01086A.", "ArticleIdList": ["10.1039/C7FO01086A", "29034918"]}, {"Citation": "Poulsen M.M., Fjeldborg K., Ornstrup M.J., Kjaer T.N., Nohr M.K., Pedersen S.B. Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes. Biochim. Biophys. Acta. 2015;1852:1124\u20131136. doi: 10.1016/j.bbadis.2014.12.024.", "ArticleIdList": ["10.1016/j.bbadis.2014.12.024", "25583116"]}, {"Citation": "Yin S.Y., Wei W.C., Jian F.Y., Yang N.S. Therapeutic applications of herbal medicines for cancer patients. Evid. Based Complement. Altern. Med. 2013;2013:302426. doi: 10.1155/2013/302426.", "ArticleIdList": ["10.1155/2013/302426"]}, {"Citation": "Glasgow M.D., Chougule M.B. Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging. J. Biomed. Nanotechnol. 2015;11:1859\u20131898. doi: 10.1166/jbn.2015.2145.", "ArticleIdList": ["10.1166/jbn.2015.2145", "PMC4816444", "26554150"]}, {"Citation": "Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: A molecule whose time has come? And gone? Clin. Biochem. 1997;30:91\u2013113. doi: 10.1016/S0009-9120(96)00155-5.", "ArticleIdList": ["10.1016/S0009-9120(96)00155-5", "9127691"]}, {"Citation": "Salehi B., Mishra A.P., Nigam M., Sener B., Kilic M., Sharifi-Rad M., Fokou P.V.T., Martins N., Sharifi-Rad J. Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines. 2018;6:91. doi: 10.3390/biomedicines6030091.", "ArticleIdList": ["10.3390/biomedicines6030091"]}, {"Citation": "Chen W.-M., Shaw L.-H., Chang P.-J., Tung S.-Y., Chang T.-S., Shen C.-H., Hsieh Y.-Y., Wei K.-L. Hepatoprotective effect of resveratrol against ethanol-induced oxidative stress through induction of superoxide dismutase in vivo and in vitro. Exp. Ther. Med. 2016;11:1231\u20131238. doi: 10.3892/etm.2016.3077.", "ArticleIdList": ["10.3892/etm.2016.3077", "PMC4812565", "27073428"]}, {"Citation": "Mokni M., Elkahoui S., Limam F., Amri M., Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem. Res. 2007;32:981\u2013987. doi: 10.1007/s11064-006-9255-z.", "ArticleIdList": ["10.1007/s11064-006-9255-z", "17401679"]}, {"Citation": "Robb E.L., Winkelmolen L., Visanji N., Brotchie J., Stuart J.A. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem. Biophys. Res. Commun. 2008;372:254\u2013259. doi: 10.1016/j.bbrc.2008.05.028.", "ArticleIdList": ["10.1016/j.bbrc.2008.05.028", "18486604"]}, {"Citation": "Kitada M., Kume S., Imaizumi N., Koya D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes. 2011;60:634\u2013643. doi: 10.2337/db10-0386.", "ArticleIdList": ["10.2337/db10-0386", "PMC3028365", "21270273"]}, {"Citation": "Sharma S., Anjaneyulu M., Kulkarni S., Chopra K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology. 2006;76:69\u201375. doi: 10.1159/000089720.", "ArticleIdList": ["10.1159/000089720", "16286809"]}, {"Citation": "Gupta S.C., Kannappan R., Reuter S., Kim J.H., Aggarwal B.B. Chemosensitization of tumors by resveratrol. Ann. N. Y. Acad. Sci. 2011;1215:150\u2013160. doi: 10.1111/j.1749-6632.2010.05852.x.", "ArticleIdList": ["10.1111/j.1749-6632.2010.05852.x", "PMC3060406", "21261654"]}, {"Citation": "Opipari A.W., Jr., Tan L., Boitano A.E., Sorenson D.R., Aurora A., Liu J.R. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res. 2004;64:696\u2013703. doi: 10.1158/0008-5472.CAN-03-2404.", "ArticleIdList": ["10.1158/0008-5472.CAN-03-2404", "14744787"]}, {"Citation": "Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res. 2004;24:2783\u20132840.", "ArticleIdList": ["15517885"]}, {"Citation": "Tome-Carneiro J., Larrosa M., Gonzalez-Sarrias A., Tomas-Barberan F.A., Garcia-Conesa M.T., Espin J.C. Resveratrol and clinical trials: The crossroad from in vitro studies to human evidence. Curr. Pharm. Des. 2013;19:6064\u20136093. doi: 10.2174/13816128113199990407.", "ArticleIdList": ["10.2174/13816128113199990407", "PMC3782695", "23448440"]}, {"Citation": "Kundu J.K., Surh Y.J. Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett. 2008;269:243\u2013261. doi: 10.1016/j.canlet.2008.03.057.", "ArticleIdList": ["10.1016/j.canlet.2008.03.057", "18550275"]}, {"Citation": "Almatroodi S.A., Syed M.A., Rahmani A.H. Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer. Recent. Pat. Anticancer Drug Discov. 2021;16:3\u201329. doi: 10.2174/1574892815999201102214602.", "ArticleIdList": ["10.2174/1574892815999201102214602", "33143616"]}, {"Citation": "Almatroudi A., Alsahli M.A., Alrumaihi F., Allemailem K.S., Rahmani A.H. Ginger: A Novel Strategy to Battle Cancer through Modulating Cell Signalling Pathways: A Review. Curr. Pharm. Biotechnol. 2019;20:5\u201316. doi: 10.2174/1389201020666190119142331.", "ArticleIdList": ["10.2174/1389201020666190119142331", "30659535"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Almatroudi A., Rahmani A.H. Garlic and its Active Compounds: A Potential Candidate in The Prevention of Cancer by Modulating Various Cell Signalling Pathways. Anticancer Agents Med. Chem. 2019;19:1314\u20131324. doi: 10.2174/1871520619666190409100955.", "ArticleIdList": ["10.2174/1871520619666190409100955", "30963982"]}, {"Citation": "Leonard S.S., Xia C., Jiang B.H., Stinefelt B., Klandorf H., Harris G.K., Shi X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003;309:1017\u20131026. doi: 10.1016/j.bbrc.2003.08.105.", "ArticleIdList": ["10.1016/j.bbrc.2003.08.105", "13679076"]}, {"Citation": "Kong D., Yan Y., He X.Y., Yang H., Liang B., Wang J., He Y., Ding Y., Yu H. Effects of Resveratrol on the Mechanisms of Antioxidants and Estrogen in Alzheimer\u2019s Disease. BioMed Res. Int. 2019;2019:8983752. doi: 10.1155/2019/8983752.", "ArticleIdList": ["10.1155/2019/8983752", "PMC6446083", "31016201"]}, {"Citation": "Khan M.A., Chen H.C., Wan X.X., Tania M., Xu A.H., Chen F.Z., Zhang D.Z. Regulatory effects of resveratrol on antioxidant enzymes: A mechanism of growth inhibition and apoptosis induction in cancer cells. Mol. Cells. 2013;35:219\u2013225. doi: 10.1007/s10059-013-2259-z.", "ArticleIdList": ["10.1007/s10059-013-2259-z", "PMC3887918", "23456297"]}, {"Citation": "Sengottuvelan M., Deeptha K., Nalini N. Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis. Chem. Biol. Interact. 2009;181:193\u2013201. doi: 10.1016/j.cbi.2009.06.004.", "ArticleIdList": ["10.1016/j.cbi.2009.06.004", "19523937"]}, {"Citation": "Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u2013444. doi: 10.1038/nature07205.", "ArticleIdList": ["10.1038/nature07205", "18650914"]}, {"Citation": "Aggarwal B.B., Gehlot P. Inflammation and cancer: How friendly is the relationship for cancer patients? Curr. Opin. Pharmacol. 2009;9:351\u2013369. doi: 10.1016/j.coph.2009.06.020.", "ArticleIdList": ["10.1016/j.coph.2009.06.020", "PMC2730981", "19665429"]}, {"Citation": "Grivennikov S.I., Karin M. Inflammation and oncogenesis: A vicious connection. Curr. Opin. Genet. Dev. 2010;20:65\u201371. doi: 10.1016/j.gde.2009.11.004.", "ArticleIdList": ["10.1016/j.gde.2009.11.004", "PMC2821983", "20036794"]}, {"Citation": "Wang G., Hu Z., Song X., Cui Q., Fu Q., Jia R., Zou Y., Li L., Yin Z. Analgesic and Anti-Inflammatory Activities of Resveratrol through Classic Models in Mice and Rats. Evid. Based Complement. Alternat. Med. 2017;2017:5197567. doi: 10.1155/2017/5197567.", "ArticleIdList": ["10.1155/2017/5197567", "PMC5366799", "28386290"]}, {"Citation": "Chen J., Cao X., Cui Y., Zeng G., Chen J., Zhang G. Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells. Mol. Med. Rep. 2018;17:4011\u20134018. doi: 10.3892/mmr.2017.8300.", "ArticleIdList": ["10.3892/mmr.2017.8300", "29257345"]}, {"Citation": "Lao L.J., Song X.J., Xu J. Effect of Resveratrol in Regulating Proliferation and Apoptosis of Rectal Cancer Cells via Up-Regulating PTEN. China J. Chin. Mater. Med. 2017;42:1730\u20131735."}, {"Citation": "Dhar S., Kumar A., Li K., Tzivion G., Levenson A.S. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochim. Biophys. Acta Mol. Cell Res. 2015;1853:265\u2013275. doi: 10.1016/j.bbamcr.2014.11.004.", "ArticleIdList": ["10.1016/j.bbamcr.2014.11.004", "25447541"]}, {"Citation": "Lin H.Y., Lansing L., Merillon J.M., Davis F.B., Tang H.Y., Shih A., Vitrac X., Krisa S., Keating T., Cao H.J., et al. Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB J. 2006;20:1742\u20131744. doi: 10.1096/fj.06-5743fje.", "ArticleIdList": ["10.1096/fj.06-5743fje", "16790523"]}, {"Citation": "Huang C., Ma W.Y., Goranson A., Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis. 1999;20:237\u2013242. doi: 10.1093/carcin/20.2.237.", "ArticleIdList": ["10.1093/carcin/20.2.237", "10069459"]}, {"Citation": "She Q.B., Bode A.M., Ma W.Y., Chen N.Y., Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 2001;61:1604\u20131610.", "ArticleIdList": ["11245472"]}, {"Citation": "Takashina M., Inoue S., Tomihara K., Tomita K., Hattori K., Zhao Q., Suzuki T., Noguchi M., Ohashi W., Hattori Y. Different effect of resveratrol to induction of apoptosis depending on the type of human cancer cells. Int. J. Oncol. 2017;50:787\u2013797. doi: 10.3892/ijo.2017.3859.", "ArticleIdList": ["10.3892/ijo.2017.3859", "28197625"]}, {"Citation": "Khanzadeh T., Hagh M.F., Talebi M., Yousefi B., Azimi A., Hossein Pour Feizi A.A., Baradaran B. Investigation of BAX and BCL2 expression and apoptosis in a resveratrol- and prednisolone-treated human T-ALL cell line, CCRF-CEM. Blood Res. 2018;53:53\u201360. doi: 10.5045/br.2018.53.1.53.", "ArticleIdList": ["10.5045/br.2018.53.1.53", "PMC5898995", "29662863"]}, {"Citation": "Nakagawa H., Kiyozuka Y., Uemura Y., Senzaki H., Shikata N., Hioki K., Tsubura A. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J. Cancer Res. Clin. Oncol. 2001;127:258\u2013264. doi: 10.1007/s004320000190.", "ArticleIdList": ["10.1007/s004320000190", "11315261"]}, {"Citation": "Joe A.K., Liu H., Suzui M., Vural M.E., Xiao D., Weinstein I.B. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 2002;8:893\u2013903.", "ArticleIdList": ["11895924"]}, {"Citation": "Shih A., Davis F.B., Lin H.Y., Davis P.J. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J. Clin. Endocrinol. Metab. 2002;87:1223\u20131232. doi: 10.1210/jcem.87.3.8345.", "ArticleIdList": ["10.1210/jcem.87.3.8345", "11889192"]}, {"Citation": "Tinhofer I., Bernhard D., Senfter M., Anether G., Loeffler M., Kroemer G., Kofler R., Csordas A., Greil R. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J. 2001;15:1613\u20131615. doi: 10.1096/fj.00-0675fje.", "ArticleIdList": ["10.1096/fj.00-0675fje", "11427503"]}, {"Citation": "Mahyar-Roemer M., Kohler H., Roemer K. Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer. 2002;2:27. doi: 10.1186/1471-2407-2-27.", "ArticleIdList": ["10.1186/1471-2407-2-27", "PMC130964", "12383351"]}, {"Citation": "Zhang W., Wang X., Chen T. Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells. Cell Signal. 2012;24:1037\u20131046. doi: 10.1016/j.cellsig.2011.12.025.", "ArticleIdList": ["10.1016/j.cellsig.2011.12.025", "22245142"]}, {"Citation": "Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis\u2014Correlation in invasive breast carcinoma. N. Engl. J. Med. 1991;324:1\u20138. doi: 10.1056/NEJM199101033240101.", "ArticleIdList": ["10.1056/NEJM199101033240101"]}, {"Citation": "Weidner N. Angiogenesis as a predictor of clinical outcome in cancer patients. Hum. Pathol. 2000;31:403\u2013405. doi: 10.1053/hp.2000.6724.", "ArticleIdList": ["10.1053/hp.2000.6724", "10821484"]}, {"Citation": "Tseng S.H., Lin S.M., Chen J.C., Su Y.H., Huang H.Y., Chen C.K., Lin P.Y., Chen Y. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin. Cancer Res. 2004;10:2190\u20132202. doi: 10.1158/1078-0432.CCR-03-0105.", "ArticleIdList": ["10.1158/1078-0432.CCR-03-0105", "15041740"]}, {"Citation": "Kimura Y., Okuda H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J. Nutr. 2001;131:1844\u20131849. doi: 10.1093/jn/131.6.1844.", "ArticleIdList": ["10.1093/jn/131.6.1844", "11385077"]}, {"Citation": "Cao Z., Fang J., Xia C., Shi X., Jiang B.H. trans-3,4,5\u2019-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin. Cancer Res. 2004;10:5253\u20135263. doi: 10.1158/1078-0432.CCR-03-0588.", "ArticleIdList": ["10.1158/1078-0432.CCR-03-0588", "15297429"]}, {"Citation": "Bishayee A., Petit D.M., Samtani K. Angioprevention is Implicated in Resveratrol Chemoprevention of Experimental Hepatocarcinogenesis. J. Carcinog. Mutagen. 2010;1:102. doi: 10.4172/2157-2518.1000102.", "ArticleIdList": ["10.4172/2157-2518.1000102"]}, {"Citation": "Liu Z., Li Y., Yang R. Effects of resveratrol on vascular endothelial growth factor expression in osteosarcoma cells and cell proliferation. Oncol. Lett. 2012;4:837\u2013839. doi: 10.3892/ol.2012.824.", "ArticleIdList": ["10.3892/ol.2012.824", "PMC3506664", "23205110"]}, {"Citation": "Lee S.H., Koo B.S., Park S.Y., Kim Y.M. Anti-angiogenic effects of resveratrol in combination with 5-fluorouracil on B16 murine melanoma cells. Mol. Med. Rep. 2015;12:2777\u20132783. doi: 10.3892/mmr.2015.3675.", "ArticleIdList": ["10.3892/mmr.2015.3675", "25936796"]}, {"Citation": "Mischel P.S., Cloughesy T.F. Targeted molecular therapy of GBM. Brain Pathol. 2003;13:52\u201361. doi: 10.1111/j.1750-3639.2003.tb00006.x.", "ArticleIdList": ["10.1111/j.1750-3639.2003.tb00006.x", "PMC8095874", "12580545"]}, {"Citation": "Brader S., Eccles S.A. Phosphoinositide 3-kinase signaling pathways in tumor progression, invasion and angiogenesis. Tumori. 2004;90:2\u20138. doi: 10.1177/030089160409000102.", "ArticleIdList": ["10.1177/030089160409000102", "15143962"]}, {"Citation": "Wang N., He J., Pan C., Wang J., Ma M., Shi X., Xu Z. Resveratrol Activates Autophagy via the AKT/mTOR Signaling Pathway to Improve Cognitive Dysfunction in Rats With Chronic Cerebral Hypoperfusion. Front. Neurosci. 2019;13:859. doi: 10.3389/fnins.2019.00859.", "ArticleIdList": ["10.3389/fnins.2019.00859", "PMC6710371", "31481868"]}, {"Citation": "Zhuang Y., Wu H., Wang X., He J., He S., Yin Y. Resveratrol attenuates oxidative stress-induced intestinal barrier injury through PI3K/Akt-mediated Nrf2 signaling pathway. Oxid. Med. Cell Longev. 2019;759:1840. doi: 10.1155/2019/7591840.", "ArticleIdList": ["10.1155/2019/7591840"]}, {"Citation": "Chai R., Fu H., Zheng Z., Liu T., Ji S., Li G. Resveratrol inhibits proliferation and migration through SIRT1 mediated post-translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells. Mol. Med. Rep. 2017;16:8037\u20138044. doi: 10.3892/mmr.2017.7612.", "ArticleIdList": ["10.3892/mmr.2017.7612", "PMC5779887", "28983625"]}, {"Citation": "Zeng Y.-H., Zhou L.-Y., Chen Q.-Z., Li Y., Shao Y., Ren W.-Y., Liao Y.-P., Wang H., Zhu J.-H., Huang M., et al. Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells. Oncol. Rep. 2017;38:456\u2013464. doi: 10.3892/or.2017.5662.", "ArticleIdList": ["10.3892/or.2017.5662", "28534975"]}, {"Citation": "Zhong L.-X., Zhang Y., Wu M.-L., Liu Y.-N., Zhang P., Chen X.-Y., Kong Q.-Y., Liu J., Li H. Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells. Cell Death Discov. 2016;2:15071. doi: 10.1038/cddiscovery.2015.71.", "ArticleIdList": ["10.1038/cddiscovery.2015.71", "PMC4979504", "27551495"]}, {"Citation": "Peng L., Jiang D. Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition. PLoS ONE. 2018;13:e0205918. doi: 10.1371/journal.pone.0205918.", "ArticleIdList": ["10.1371/journal.pone.0205918", "PMC6200233", "30356255"]}, {"Citation": "Wang H., Feng H., Zhang Y. Resveratrol inhibits hypoxia-induced glioma cell migration and invasion by the p-STAT3/miR-34a axis. Neoplasma. 2016;63:532\u2013539. doi: 10.4149/neo_2016_406.", "ArticleIdList": ["10.4149/neo_2016_406", "27268916"]}, {"Citation": "Suh J., Kim D.H., Surh Y.J. Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Arch. Biochem. Biophys. 2018;643:62\u201371. doi: 10.1016/j.abb.2018.02.011.", "ArticleIdList": ["10.1016/j.abb.2018.02.011", "29477771"]}, {"Citation": "Baek S.H., Ko J.-H., Lee H., Jung J., Kong M., Lee J.-W., Lee J., Chinnathambi A., Zayed M., Alharbi S.A., et al. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. Phytomedicine. 2016;23:566\u2013577.", "ArticleIdList": ["27064016"]}, {"Citation": "Suzuki Y., Ito S., Sasaki R., Asahi M., Ishida Y. Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells. Leuk. Res. 2013;37:1674\u20131679. doi: 10.1016/j.leukres.2013.09.010.", "ArticleIdList": ["10.1016/j.leukres.2013.09.010", "24090995"]}, {"Citation": "Singh S.K., Banerjee S., Acosta E.P., Lillard J.W., Singh R. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget. 2017;8:17216\u201317228. doi: 10.18632/oncotarget.15303.", "ArticleIdList": ["10.18632/oncotarget.15303", "PMC5370034", "28212547"]}, {"Citation": "Yuan L., Zhang Y., Xia J., Liu B., Zhang Q., Liu J., Luo L., Peng Z., Song Z., Zhu R. Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells. Mol. Med. Rep. 2015;11:2459\u20132464. doi: 10.3892/mmr.2014.3100.", "ArticleIdList": ["10.3892/mmr.2014.3100", "PMC4337473", "25515619"]}, {"Citation": "Hu X., Wang J., Xia Y., Simayi M., Ikramullah S., He Y., Cui S., Li S., Wushouer Q. Resveratrol induces cell cycle arrest and apoptosis in human eosinophils from asthmatic individuals. Mol. Med. Rep. 2016;14:5231\u20135236. doi: 10.3892/mmr.2016.5884.", "ArticleIdList": ["10.3892/mmr.2016.5884", "27779703"]}, {"Citation": "Trung L.Q., Espinoza J.L., Takami A., Nakao S. Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT-3 pathway inhibition. PLoS ONE. 2013;8:e55183.", "ArticleIdList": ["PMC3555980", "23372833"]}, {"Citation": "Mikami S., Ota I., Masui T., Uchiyama T., Okamoto H., Kimura T., Takasawa S., Kitahara T. Resveratrol-induced REG III expression enhances chemo- and radiosensitivity in head and neck cancer in xenograft mice. Oncol. Rep. 2019;42:436\u2013442. doi: 10.3892/or.2019.7137.", "ArticleIdList": ["10.3892/or.2019.7137", "31059079"]}, {"Citation": "El Attar T.M., Virji A.S. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs. 1999;10:187\u2013193. doi: 10.1097/00001813-199902000-00007.", "ArticleIdList": ["10.1097/00001813-199902000-00007", "10211549"]}, {"Citation": "Kim S.E., Shin S.H., Lee J.Y., Kim C.H., Chung I.K., Kang H.M., Park H.R., Park B.S., Kim I.R. Resveratrol Induces Mitochondrial Apoptosis and Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells. Nutr. Cancer. 2018;70:125\u2013135. doi: 10.1080/01635581.2018.1397708.", "ArticleIdList": ["10.1080/01635581.2018.1397708", "29148840"]}, {"Citation": "Shan Z., Yang G., Xiang W., Pei-Jun W., Bin Z. Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro. J. Cancer Res. Clin. Oncol. 2014;140:371\u2013374. doi: 10.1007/s00432-013-1575-1.", "ArticleIdList": ["10.1007/s00432-013-1575-1", "24384874"]}, {"Citation": "Chang C., Lee C., Lu C., Tsai F., Hsu Y., Tsao J., Juan Y., Chiu H., Yang J., Wang C. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling. Int. J. Oncol. 2017;50:873\u2013882. doi: 10.3892/ijo.2017.3866.", "ArticleIdList": ["10.3892/ijo.2017.3866", "28197628"]}, {"Citation": "Yu X.-D., Yang J.-L., Zhang W.-L., Liu D.-X. Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest. Tumour. Biol. 2016;37:287. doi: 10.1007/s13277-015-3793-4.", "ArticleIdList": ["10.1007/s13277-015-3793-4", "26409447"]}, {"Citation": "Woodall C.E., Li Y., Liu Q.H., Wo J., Martin R.C. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation. Anticancer Drugs. 2009;20:437\u2013443. doi: 10.1097/CAD.0b013e32832afb95.", "ArticleIdList": ["10.1097/CAD.0b013e32832afb95", "19398904"]}, {"Citation": "Tang Q., Li G., Wei X., Zhang J., Chiu J.-F., Hasenmayer D., Zhang D., Zhang H. Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma. Cancer Lett. 2013;336:325\u2013337. doi: 10.1016/j.canlet.2013.03.023.", "ArticleIdList": ["10.1016/j.canlet.2013.03.023", "23541682"]}, {"Citation": "Li Z.G., Hong T., Shimada Y., Komoto I., Kawabe A., Ding Y., Kaganoi J., Hashimoto Y., Imamura M. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis. 2002;23:1531\u20131536. doi: 10.1093/carcin/23.9.1531.", "ArticleIdList": ["10.1093/carcin/23.9.1531", "12189197"]}, {"Citation": "Zhou H.B., Yan Y., Sun Y.N., Zhu J.R. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J. Gastroenterol. 2003;9:408\u2013411. doi: 10.3748/wjg.v9.i3.408.", "ArticleIdList": ["10.3748/wjg.v9.i3.408", "PMC4621550", "12632486"]}, {"Citation": "Rasheduzzaman M., Jeong J.K., Park S.Y. Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-\u03baB signaling. Life Sci. 2018;208:208\u2013220. doi: 10.1016/j.lfs.2018.07.035.", "ArticleIdList": ["10.1016/j.lfs.2018.07.035", "30031063"]}, {"Citation": "Wang J., Li J., Cao N., Li Z., Han J., Li L. Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK. Onco Targets Ther. 2018;11:7777\u20137786. doi: 10.2147/OTT.S159095.", "ArticleIdList": ["10.2147/OTT.S159095", "PMC6223384", "30464525"]}, {"Citation": "Liu Y., Wu Y.M., Yu Y., Cao C.S., Zhang J.H., Li K., Zhang P.Y. Curcumin and resveratrol in combination modulate drug-metabolizing enzymes as well as antioxidant indices during lung carcinogenesis in mice. Hum. Exp. Toxicol. 2015;34:620\u2013627. doi: 10.1177/0960327114551396.", "ArticleIdList": ["10.1177/0960327114551396", "25632966"]}, {"Citation": "Nie P., Hu W., Zhang T., Yang Y., Hou B., Zou Z. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA. Cell Physiol. Biochem. 2015;35:2255\u20132271. doi: 10.1159/000374030.", "ArticleIdList": ["10.1159/000374030", "25895606"]}, {"Citation": "Yang T., Zhang J., Zhou J., Zhu M., Wang L., Yan L. Resveratrol inhibits Interleukin-6 induced invasion of human gastric cancer cells. Biomed. Pharmacother. 2018;99:766\u2013773. doi: 10.1016/j.biopha.2018.01.153.", "ArticleIdList": ["10.1016/j.biopha.2018.01.153", "29710474"]}, {"Citation": "Liu Y., Wu Y.M., Yu Y., Cao C.S., Zhang J.H., Li K., Zhang P.Y. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. J. Exp. Clin. Cancer Res. 2017;36:19.", "ArticleIdList": ["PMC5270306", "28126034"]}, {"Citation": "Wang Z., Li W., Meng X., Jia B. Resveratrol induces gastric cancer cell apoptosis via reactive oxygen species, but independent of sirtuin1. Clin. Exp. Pharmacol. Physiol. 2012;39:227\u2013232. doi: 10.1111/j.1440-1681.2011.05660.x.", "ArticleIdList": ["10.1111/j.1440-1681.2011.05660.x", "22211760"]}, {"Citation": "Roncoroni L., Elli L., Braidotti P., Tosi D., Vaira V., Tacchini L., Lombardo V., Branchi F., Scricciolo A., Doneda L. Transglutaminase 2 Mediates the Cytotoxicity of Resveratrol in a Human Cholangiocarcinoma and Gallbladder Cancer Cell Lines. Nutr. Cancer. 2018;70:761\u2013769. doi: 10.1080/01635581.2018.1470648.", "ArticleIdList": ["10.1080/01635581.2018.1470648", "29757003"]}, {"Citation": "Sheng L., An L., He Y., Fan G., Yuan Y. Research on Resveratrol\u2019s Effects on Suppressing Growth and Inducing Apoptosis of GBC Cells. J. Chin. Med. Mater. 2005;28:489\u2013491."}, {"Citation": "Jiang Q., Yang M., Qu Z., Zhou J., Zhang Q. Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells. BMC Complement. Altern. Med. 2017;17:477. doi: 10.1186/s12906-017-1956-0.", "ArticleIdList": ["10.1186/s12906-017-1956-0", "PMC5628430", "28978315"]}, {"Citation": "Parekh P., Motiwale L., Naik N., Rao K.V. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells. Exp. Toxicol. Pathol. 2011;63:167\u2013173. doi: 10.1016/j.etp.2009.11.005.", "ArticleIdList": ["10.1016/j.etp.2009.11.005", "20133117"]}, {"Citation": "Yan Y., Zhou C., Li J., Chen K., Wang G., Wei G., Chen M., Li X. Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1. Mol. Cell Biochem. 2017;434:17\u201324. doi: 10.1007/s11010-017-3031-z.", "ArticleIdList": ["10.1007/s11010-017-3031-z", "28455791"]}, {"Citation": "Cheng L., Yan B., Chen K., Jiang Z., Zhou C., Cao J., Qian W., Li J., Sun L., Ma J., et al. Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways. Oxid. Med. Cell Longev. 2018;2018:9482018. doi: 10.1155/2018/9482018.", "ArticleIdList": ["10.1155/2018/9482018", "PMC5885341", "29765509"]}, {"Citation": "Jiang Z., Chen X., Chen K., Sun L., Gao L., Zhou C., Lei M., Duan W., Ma J., Wang W., et al. YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine. Nutrients. 2016;8:546. doi: 10.3390/nu8100546.", "ArticleIdList": ["10.3390/nu8100546", "PMC5083973", "27669292"]}, {"Citation": "Qin Y., Ma Z., Dang X., Li W., Ma Q. Effect of resveratrol on proliferation and apoptosis of human pancreatic cancer MIA PaCa-2 cells may involve inhibition of the Hedgehog signaling pathway. Mol. Med. Rep. 2014;10:2563\u20132567. doi: 10.3892/mmr.2014.2511.", "ArticleIdList": ["10.3892/mmr.2014.2511", "25190613"]}, {"Citation": "Golkar L., Ding X.Z., Ujiki M.B., Salabat M.R., Kelly D.L., Scholtens D. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J. Surg. Res. 2007;138:163\u2013169. doi: 10.1016/j.jss.2006.05.037.", "ArticleIdList": ["10.1016/j.jss.2006.05.037", "17257620"]}, {"Citation": "Bernhaus A., Ozsvar-Kozma M., Saiko P., Jaschke M., Lackner A., Grusch M., Horvath Z., Madlener S., Krupitza G., Handler N., et al. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells. Investig. New Drugs. 2009;27:393\u2013401. doi: 10.1007/s10637-008-9183-7.", "ArticleIdList": ["10.1007/s10637-008-9183-7", "18841326"]}, {"Citation": "San Hip\u00f3lito-Luengo \u00c1., Alcaide A., Ramos-Gonz\u00e1lez M., Cercas E., Vallejo S., Romero A., Talero E., S\u00e1nchez-Ferrer C., Motilva V., Peir\u00f3 C. Dual Effects of Resveratrol on Cell Death and Proliferation of Colon Cancer Cells. Nutr. Cancer. 2017;69:1019\u20131027. doi: 10.1080/01635581.2017.1359309.", "ArticleIdList": ["10.1080/01635581.2017.1359309", "28937798"]}, {"Citation": "Blanquer-Rossell\u00f3 M.D., Hern\u00e1ndez-L\u00f3pez R., Roca P., Oliver J., Valle A. Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells. Biochim. Biophys. Acta Gen. Subj. 2017;1861:431\u2013440. doi: 10.1016/j.bbagen.2016.10.009.", "ArticleIdList": ["10.1016/j.bbagen.2016.10.009", "27760368"]}, {"Citation": "Li D., Wang G., Jin G., Yao K., Zhao Z., Bie L., Guo Y., Li N., Deng W., Chen X., et al. Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway. Int. J. Mol. Med. 2019;43:630\u2013640. doi: 10.3892/ijmm.2018.3969.", "ArticleIdList": ["10.3892/ijmm.2018.3969", "30387805"]}, {"Citation": "San Hip\u00f3lito-Luengo \u00c1., Alcaide A., Ramos-Gonz\u00e1lez M., Cercas E., Vallejo S., Romero A. Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells. Sci. Rep. 2017;7:6945.", "ArticleIdList": ["PMC5537345", "28761044"]}, {"Citation": "Aires V., Brassart B., Carlier A., Scagliarini A., Mandard S., Limagne E., Solary E., Martiny L., Tarpin M., Delmas D. A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis. Mol. Nutr. Food Res. 2014;58:1785\u20131794. doi: 10.1002/mnfr.201300962.", "ArticleIdList": ["10.1002/mnfr.201300962", "24975132"]}, {"Citation": "Kabel A.M., Atef A., Estfanous R.S. Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma. Biomed. Pharmacother. 2018;97:667\u2013674. doi: 10.1016/j.biopha.2017.10.149.", "ArticleIdList": ["10.1016/j.biopha.2017.10.149", "29101811"]}, {"Citation": "Liu Q., Fang Q., Ji S., Han Z., Cheng W., Zhang H. Resveratrol-mediated apoptosis in renal cell carcinoma via the p53/AMP-activated protein kinase/mammalian target of rapamycin autophagy signaling pathway. Mol. Med. Rep. 2018;17:502\u2013508. doi: 10.3892/mmr.2017.7868.", "ArticleIdList": ["10.3892/mmr.2017.7868", "29115429"]}, {"Citation": "Zeng Y., Li F.D., Shi C.W., Du J.L., Xue Y.J., Liu X.Y., Cao X., Wei N. Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma. Cancer Gene Ther. 2019;27:619\u2013623. doi: 10.1038/s41417-019-0150-6.", "ArticleIdList": ["10.1038/s41417-019-0150-6", "31664166"]}, {"Citation": "Wang D., Gao Z., Zhang X. Resveratrol Induces Apoptosis in Murine Prostate Cancer Cells via Hypoxia-Inducible Factor 1-alpha (HIF-1\u03b1)/Reactive Oxygen Species (ROS)/P53 Signaling. Med. Sci. Monit. 2018;24:8970\u20138976. doi: 10.12659/MSM.913290.", "ArticleIdList": ["10.12659/MSM.913290", "PMC6298174", "30531685"]}, {"Citation": "Vancauwenberghe E., Noyer L., Derouiche S., Lemonnier L., Gosset P., Sadofsky L.R., Mariot P., Warnier M., Bokhobza A., Slomianny C., et al. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF) Mol. Carcinog. 2017;56:1851\u20131867. doi: 10.1002/mc.22642.", "ArticleIdList": ["10.1002/mc.22642", "28277613"]}, {"Citation": "Alayev A., Salamon R.S., Schwartz N.S., Berman A.Y., Wiener S.L., Holz M.K. Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer. J. Cell Physiol. 2017;232:436\u2013446. doi: 10.1002/jcp.25443.", "ArticleIdList": ["10.1002/jcp.25443", "27225870"]}, {"Citation": "Bai Y., Yang H., Zhang G., Hu L., Lei Y., Qin Y., Yang Y., Wang Q., Li R., Mao Q. Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells. Mol. Med. Rep. 2017;15:885\u2013889. doi: 10.3892/mmr.2016.6051.", "ArticleIdList": ["10.3892/mmr.2016.6051", "28000872"]}, {"Citation": "Almeida T.C., Guerra C.C., De Assis B.L., de Oliveira Aguiar Soares R.D., Garcia C.C., Lima A.A., da Silva G.N. Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status. Environ. Mol. Mutagen. 2019;60:740\u2013751. doi: 10.1002/em.22297.", "ArticleIdList": ["10.1002/em.22297", "31095781"]}, {"Citation": "Stocco B., Toledo K., Salvador M., Paulo M., Koyama N., Torqueti Toloi M.R. Dose-dependent effect of resveratrol on bladder cancer cells: Chemoprevention and oxidative stress. Maturitas. 2012;72:72\u201378. doi: 10.1016/j.maturitas.2012.02.004.", "ArticleIdList": ["10.1016/j.maturitas.2012.02.004", "22386766"]}, {"Citation": "Bai Y., Mao Q.Q., Qin J., Zheng X.Y., Wang Y.B., Yang K., Shen H.F., Xie L.P. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 2010;101:488\u2013493. doi: 10.1111/j.1349-7006.2009.01415.x.", "ArticleIdList": ["10.1111/j.1349-7006.2009.01415.x", "20028382"]}, {"Citation": "Zhang W., Jiang H., Chen Y., Ren F. Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p. J. Cell Biochem. 2019;120:16283\u201316292. doi: 10.1002/jcb.28910.", "ArticleIdList": ["10.1002/jcb.28910", "31155753"]}, {"Citation": "Gao Y., Tollefsbol T.O. Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic\u2013Mediating Machinery. Int. J. Mol. Sci. 2018;19:2204. doi: 10.3390/ijms19082204.", "ArticleIdList": ["10.3390/ijms19082204", "PMC6121898", "30060527"]}, {"Citation": "Deus C.M., Serafim T.L., Magalh\u00e3es-Novais S., Vila\u00e7a A., Moreira A.C., Sard\u00e3o V.A., Cardoso S., Oliveira P.J. Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells. Arch. Toxicol. 2017;91:1261\u20131278. doi: 10.1007/s00204-016-1784-x.", "ArticleIdList": ["10.1007/s00204-016-1784-x", "27358235"]}, {"Citation": "Fukuda T., Oda K., Wada-Hiraike O., Sone K., Inaba K., Ikeda Y., Makii C., Miyasaka A., Kashiyama T., Tanikawa M., et al. Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells. Oncol. Lett. 2016;12:2560\u20132566. doi: 10.3892/ol.2016.4978.", "ArticleIdList": ["10.3892/ol.2016.4978", "PMC5038194", "27698828"]}, {"Citation": "Kaneuchi M., Sasaki M., Tanaka Y., Yamamoto R., Sakuragi N., Dahiya R. Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. Int. J. Oncol. 2003;23:1167\u20131172. doi: 10.3892/ijo.23.4.1167.", "ArticleIdList": ["10.3892/ijo.23.4.1167", "12964000"]}, {"Citation": "Bhat K.P., Pezzuto J.M. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res. 2001;61:6137\u20136144.", "ArticleIdList": ["11507064"]}, {"Citation": "Garc\u00eda-Zepeda S.P., Garc\u00eda-Villa E., D\u00edaz-Ch\u00e1vez J., Hern\u00e1ndez-Pando R., Gariglio P. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy. Eur. J. Cancer Prev. 2013;22:577\u2013584. doi: 10.1097/CEJ.0b013e328360345f.", "ArticleIdList": ["10.1097/CEJ.0b013e328360345f", "23603746"]}, {"Citation": "Zhang P., Yang B., Yao Y.Y., Zhong L.X., Chen X.Y., Kong Q.Y., Wu M.L., Li C., Li H., Liu J. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling. Gynecol. Oncol. 2015;139:529\u2013535. doi: 10.1016/j.ygyno.2015.09.087.", "ArticleIdList": ["10.1016/j.ygyno.2015.09.087", "26432044"]}, {"Citation": "Hsu K.F., Wu C.L., Huang S.C., Wu C.M., Hsiao J.R., Yo Y.T., Chen Y.H., Shiau A.L., Chou C.Y. Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells. Autophagy. 2009;5:451\u2013460. doi: 10.4161/auto.5.4.7666.", "ArticleIdList": ["10.4161/auto.5.4.7666", "19164894"]}, {"Citation": "Ferraresi A., Phadngam S., Morani F., Galetto A., Alabiso O., Chiorino G., Isidoro C. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy. Mol. Carcinog. 2017;56:1164\u20131181. doi: 10.1002/mc.22582.", "ArticleIdList": ["10.1002/mc.22582", "27787915"]}, {"Citation": "Zhong L.X., Nie J.H., Liu J., Lin L.Z. Correlation of ARHI upregulation with growth suppression and STAT3 inactivation in resveratrol-treated ovarian cancer cells. Cancer Biomark. 2018;21:787\u2013795. doi: 10.3233/CBM-170483.", "ArticleIdList": ["10.3233/CBM-170483", "29504523"]}, {"Citation": "Kim S.H., Cho K.H., Kim Y.N., Jeong B.Y., Park C.G., Hur G.M., Lee H.Y. Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression. Arch. Pharm. Res. 2016;39:240\u2013248. doi: 10.1007/s12272-015-0666-8.", "ArticleIdList": ["10.1007/s12272-015-0666-8", "26428673"]}, {"Citation": "Kim T.H., Park J.H., Woo J.S. Resveratrol induces cell death through ROS-dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells. Mol. Med. Rep. 2019;19:3353\u20133360. doi: 10.3892/mmr.2019.9962.", "ArticleIdList": ["10.3892/mmr.2019.9962", "30816513"]}, {"Citation": "Mineda A., Nishimura M., Kagawa T., Takiguchi E., Kawakita T., Abe A., Irahara M. Resveratrol suppresses proliferation and induces apoptosis of uterine sarcoma cells by inhibiting the Wnt signaling pathway. Exp. Ther. Med. 2019;17:2242\u20132246. doi: 10.3892/etm.2019.7209.", "ArticleIdList": ["10.3892/etm.2019.7209", "PMC6396019", "30867708"]}, {"Citation": "Sui X., Zhang C., Zhou J., Cao S., Xu C., Tang F., Zhi X., Chen B., Wang S., Yin L. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway. J. Exp. Clin. Cancer Res. 2017;36:133. doi: 10.1186/s13046-017-0601-6.", "ArticleIdList": ["10.1186/s13046-017-0601-6", "PMC5615630", "28950914"]}, {"Citation": "Jara P., Spies J., C\u00e1rcamo C., Arancibia Y., Vargas G., Martin C., Salas M., Otth C., Zambrano A. The Effect of Resveratrol on Cell Viability in the Burkitt\u2019s Lymphoma Cell Line Ramos. Molecules. 2017;23:14. doi: 10.3390/molecules23010014.", "ArticleIdList": ["10.3390/molecules23010014", "PMC5943955", "29267250"]}, {"Citation": "Frazzi R., Valli R., Tamagnini I., Casali B., Latruffe N., Merli F. Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation. Int. J. Cancer. 2013;132:1013\u20131021. doi: 10.1002/ijc.27748.", "ArticleIdList": ["10.1002/ijc.27748", "22833338"]}, {"Citation": "Faber A.C., Chiles T.C. Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: Evidence for a novel mechanism involving inhibition of BCL6 signaling. Int. J. Oncol. 2006;29:1561\u20131566. doi: 10.3892/ijo.29.6.1561.", "ArticleIdList": ["10.3892/ijo.29.6.1561", "17088997"]}, {"Citation": "De Leo A., Arena G., Lacanna E., Oliviero G., Colavita F., Mattia E. Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt\u2019s lymphoma cells by affecting multiple molecular targets. Antivir. Res. 2012;96:196\u2013202. doi: 10.1016/j.antiviral.2012.09.003.", "ArticleIdList": ["10.1016/j.antiviral.2012.09.003", "22985630"]}, {"Citation": "Jin H.G., Wu G.Z., Wu G.H., Bao Y.G. Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma. Oncol. Lett. 2018;15:6257\u20136264. doi: 10.3892/ol.2018.8178.", "ArticleIdList": ["10.3892/ol.2018.8178", "PMC5920858", "29731844"]}, {"Citation": "Li Q., Yue Y., Chen L., Xu C., Wang Y., Du L., Xue X., Liu Q., Wang Y., Fan F. Resveratrol Sensitizes Carfilzomib-Induced Apoptosis via Promoting Oxidative Stress in Multiple Myeloma Cells. Front. Pharmacol. 2018;9:334. doi: 10.3389/fphar.2018.00334.", "ArticleIdList": ["10.3389/fphar.2018.00334", "PMC5961230", "29867453"]}, {"Citation": "Lei M.J., Dong Y., Sun C.X., Zhang X.H. Resveratrol inhibits proliferation, promotes differentiation and melanogenesis in HT-144 melanoma cells through inhibition of MEK/ERK kinase pathway. Microb. Pathog. 2017;111:410\u2013413. doi: 10.1016/j.micpath.2017.09.029.", "ArticleIdList": ["10.1016/j.micpath.2017.09.029", "28919486"]}, {"Citation": "Cheng Y.J., Chang M.Y., Chang W.W., Wang W.K., Liu C.F., Lin S.T., Lee C.H. Resveratrol Enhances Chemosensitivity in Mouse Melanoma Model Through Connexin 43 Upregulation. Environ. Toxicol. 2015;30:877\u2013886. doi: 10.1002/tox.21952.", "ArticleIdList": ["10.1002/tox.21952", "24449132"]}, {"Citation": "Wu Z., Liu B., Liu J., Zhang Q., Liu J., Chen N., Chen R., Zhu R. Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis. Mol. Med. Rep. 2015;11:400\u2013404. doi: 10.3892/mmr.2014.2716.", "ArticleIdList": ["10.3892/mmr.2014.2716", "25333673"]}, {"Citation": "Yang H.Z., Zhang J., Zeng J., Liu S., Zhou F., Zhang F., Giampieri F., Cianciosi D., Forbes-Hernandez T.Y., Ansary J., et al. Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycle. Int. J. Food Sci. Nutr. 2020;71:84\u201393. doi: 10.1080/09637486.2019.1614541.", "ArticleIdList": ["10.1080/09637486.2019.1614541", "31154861"]}, {"Citation": "Tian H., Yu Z. Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway. Int. J. Clin. Exp. Pathol. 2015;8:2755\u20132762.", "ArticleIdList": ["PMC4440090", "26045781"]}, {"Citation": "Siedlecka-Kroplewska K., Wozniak M., Kmiec Z. The wine polyphenol resveratrol modulates autophagy and induces apoptosis in MOLT-4 and HL-60 human leukemia cells. J. Physiol. Pharmacol. 2019;70:26402."}, {"Citation": "Xu N., Wang L., Fu S., Jiang B. Resveratrol is cytotoxic and acts synergistically with NF-\u03baB inhibition in osteosarcoma MG-63 cells. Arch. Med. Sci. 2020;17:166\u2013176. doi: 10.5114/aoms.2020.100777.", "ArticleIdList": ["10.5114/aoms.2020.100777", "PMC7811305", "33488869"]}, {"Citation": "Zou Y., Yang J., Jiang D. Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells. Mol. Med. Rep. 2015;12:7221\u20137226. doi: 10.3892/mmr.2015.4338.", "ArticleIdList": ["10.3892/mmr.2015.4338", "PMC4626196", "26398440"]}, {"Citation": "Xiao X., Zhang Y., Pan W., Chen F. miR-139-mediated NOTCH1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol. Life Sci. 2020;242:117215. doi: 10.1016/j.lfs.2019.117215.", "ArticleIdList": ["10.1016/j.lfs.2019.117215", "31881225"]}, {"Citation": "Zheng X., Jia B., Tian X.T., Song X., Wu M.L., Kong Q.Y., Li H., Liu J. Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells. Oxid. Med. Cell Longev. 2018;2018:6235417. doi: 10.1155/2018/6235417.", "ArticleIdList": ["10.1155/2018/6235417", "PMC6079360", "30116486"]}, {"Citation": "Hosseinimehr S.J., Hosseini S.A. Resveratrol sensitizes selectively thyroid cancer cell to 131-iodine toxicity. J. Toxicol. 2014;2014:839597. doi: 10.1155/2014/839597.", "ArticleIdList": ["10.1155/2014/839597", "PMC4170962", "25276125"]}, {"Citation": "Clark P.A., Bhattacharya S., Elmayan A., Darjatmoko S.R., Thuro B.A., Yan M.B., van Ginkel P.R., Polans A.S., Kuo J.S. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. J. Neurosurg. 2017;126:1448\u20131460. doi: 10.3171/2016.1.JNS152077.", "ArticleIdList": ["10.3171/2016.1.JNS152077", "PMC5237623", "27419830"]}, {"Citation": "Li H., Liu Y., Jiao Y., Guo A., Xu X., Qu X., Wang S., Zhao J., Li Y., Cao Y. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation. Oncol. Rep. 2016;35:343\u2013351. doi: 10.3892/or.2015.4346.", "ArticleIdList": ["10.3892/or.2015.4346", "26498391"]}, {"Citation": "\u00d6zt\u00fcrk Y., G\u00fcnayd\u0131n C., Yal\u00e7\u0131n F., Naz\u0131ro\u011flu M., Braidy N. Resveratrol Enhances Apoptotic and Oxidant Effects of Paclitaxel through TRPM2 Channel Activation in DBTRG Glioblastoma Cells. Oxid. Med. Cell Longev. 2019;2019:4619865. doi: 10.1155/2019/4619865.", "ArticleIdList": ["10.1155/2019/4619865", "PMC6431513", "30984336"]}, {"Citation": "Li W., Shi Y., Wang R., Pan L., Ma L., Jin F. Resveratrol promotes the sensitivity of small-cell lung cancer H446 cells to cisplatin by regulating intrinsic apoptosis. Int. J. Oncol. 2018;53:2123\u20132130. doi: 10.3892/ijo.2018.4533.", "ArticleIdList": ["10.3892/ijo.2018.4533", "30132509"]}, {"Citation": "Wright C., Iyer A.K.V., Yakisich J.S., Azad N. Anti-Tumorigenic Effects of Resveratrol in Lung Cancer Cells Through Modulation of c-FLIP. Curr. Cancer Drug Targets. 2017;17:669\u2013680. doi: 10.2174/1568009617666170315162932.", "ArticleIdList": ["10.2174/1568009617666170315162932", "PMC6476192", "28302032"]}, {"Citation": "Dai H., Deng H.B., Wang Y.H., Guo J.J. Resveratrol inhibits the growth of gastric cancer via the Wnt/\u03b2-catenin pathway. Oncol. Lett. 2018;16:1579\u20131583. doi: 10.3892/ol.2018.8772.", "ArticleIdList": ["10.3892/ol.2018.8772", "PMC6036503", "30008840"]}, {"Citation": "Wu X., Xu Y., Zhu B., Liu Q., Yao Q., Zhao G. Resveratrol induces apoptosis in SGC-7901 gastric cancer cells. Oncol. Lett. 2018;16:2949\u20132956. doi: 10.3892/ol.2018.9045.", "ArticleIdList": ["10.3892/ol.2018.9045", "PMC6096135", "30127883"]}, {"Citation": "Yang Y., Huang X., Chen S., Ma G., Zhu M., Yan F., Yu J. Resveratrol induced apoptosis in human gastric carcinoma SGC-7901 cells via activation of mitochondrial pathway. Asia-Pac. J. Clin. Oncol. 2018;14:e317\u2013e324. doi: 10.1111/ajco.12841.", "ArticleIdList": ["10.1111/ajco.12841", "29316254"]}, {"Citation": "Holian O., Wahid S., Atten M.J., Attar B.M. Inhibition of gastric cancer cell proliferation by resveratrol: Role of nitric oxide. Am. J. Physiol. Gastrointest Liver Physiol. 2002;282:G809\u2013G816. doi: 10.1152/ajpgi.00193.2001.", "ArticleIdList": ["10.1152/ajpgi.00193.2001", "11960777"]}, {"Citation": "Thongchot S., Ferraresi A., Vidoni C., Loilome W., Yongvanit P., Namwat N., Isidoro C. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. Cancer Lett. 2018;430:160\u2013171. doi: 10.1016/j.canlet.2018.05.031.", "ArticleIdList": ["10.1016/j.canlet.2018.05.031", "29802929"]}, {"Citation": "Zhang B., Yin X., Sui S. Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3-kinase/protein kinase B pathway. Oncol. Rep. 2018;40:2758\u20132765. doi: 10.3892/or.2018.6648.", "ArticleIdList": ["10.3892/or.2018.6648", "30132535"]}, {"Citation": "Gao F., Deng G., Liu W., Zhou K., Li M. Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway. Oncol. Rep. 2017;37:1203\u20131211. doi: 10.3892/or.2017.5347.", "ArticleIdList": ["10.3892/or.2017.5347", "28075467"]}, {"Citation": "Charytoniuk T., Harasim-Symbor E., Polak A., Drygalski K., Berk K., Chabowski A., Konstantynowicz-Nowicka K. Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State. Anticancer Agents Med. Chem. 2019;19:121\u2013129. doi: 10.2174/1871520619666181224161255.", "ArticleIdList": ["10.2174/1871520619666181224161255", "30585550"]}, {"Citation": "Kato A., Naiki-Ito A., Nakazawa T., Hayashi K., Naitoh I., Miyabe K., Takahashi S. Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3\u03b2 and ERK1/2. Oncotarget. 2015;6:42963\u201342975. doi: 10.18632/oncotarget.5981.", "ArticleIdList": ["10.18632/oncotarget.5981", "PMC4767484", "26556864"]}, {"Citation": "Yang L., Yang L., Tian W., Li J., Liu J., Zhu M., Zhang Y., Yang Y., Liu F., Qi Z., et al. Resveratrol plays dual roles in pancreatic cancer cells. J. Cancer Res. Clin. Oncol. 2014;140:749\u2013755. doi: 10.1007/s00432-014-1624-4.", "ArticleIdList": ["10.1007/s00432-014-1624-4", "24604347"]}, {"Citation": "Yan C., Li F., Zhang Y., Li Y., Li M., Wang F., Zhang G., Li Y., Li B., Zhao X. Effects of As2O3 and Resveratrol on the Proliferation and Apoptosis of Colon Cancer Cells and the hERG-mediated Potential Mechanisms. Curr. Pharm. Des. 2019;25:1385\u20131391. doi: 10.2174/1381612817666190619123610.", "ArticleIdList": ["10.2174/1381612817666190619123610", "PMC7040501", "31218953"]}, {"Citation": "Feng M., Zhong L.X., Zhan Z.Y., Huang Z.H., Xiong J.P. Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells. Med. Sci. Monit. 2016;22:1101\u20131108. doi: 10.12659/MSM.897905.", "ArticleIdList": ["10.12659/MSM.897905", "PMC4822945", "27040803"]}, {"Citation": "Zhao Y., Tang H., Zeng X., Ye D., Liu J. Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells. Biomed. Pharmacother. 2018;98:36\u201344. doi: 10.1016/j.biopha.2017.12.029.", "ArticleIdList": ["10.1016/j.biopha.2017.12.029", "29241073"]}, {"Citation": "Jeong S.H., Lee J.S., Jeong N.Y., Kim T.H., Yoo K.S., Song S., Suh H., Kwon T.K., Park B.S., Yoo Y.H. A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells. Int. J. Oncol. 2009;35:1353\u20131360.", "ArticleIdList": ["19885558"]}, {"Citation": "Jang Y.G., Go R.E., Hwang K.A., Choi K.C. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway. J. Steroid. Biochem. Mol. Biol. 2019;192:105406. doi: 10.1016/j.jsbmb.2019.105406.", "ArticleIdList": ["10.1016/j.jsbmb.2019.105406", "31185279"]}, {"Citation": "Wilson S., Cavero L., Tong D., Liu Q., Geary K., Talamonti N., Xu J., Fu J., Jiang J., Zhang D. Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells. Oncotarget. 2017;8:54683\u201354693. doi: 10.18632/oncotarget.18003.", "ArticleIdList": ["10.18632/oncotarget.18003", "PMC5589613", "28903374"]}, {"Citation": "Carter L.G., D\u2019Orazio J.A., Pearson K.J. Resveratrol and cancer: Focus on in vivo evidence. Endocrine-Related Cancer. 2014;21:R209\u2013R225. doi: 10.1530/ERC-13-0171.", "ArticleIdList": ["10.1530/ERC-13-0171", "PMC4013237", "24500760"]}, {"Citation": "Zhou C., Ding J., Wu Y. Resveratrol induces apoptosis of bladder cancer cells via miR-21 regulation of the Akt/Bcl-2 signaling pathway. Mol. Med. Rep. 2014;9:1467\u20131473. doi: 10.3892/mmr.2014.1950.", "ArticleIdList": ["10.3892/mmr.2014.1950", "24535223"]}, {"Citation": "Hu C., Liu Y., Teng M., Jiao K., Zhen J., Wu M., Li Z. Resveratrol inhibits the proliferation of estrogen receptor-positive breast cancer cells by suppressing EZH2 through the modulation of ERK1/2 signaling. Cell Biol. Toxicol. 2019;35:445\u2013456. doi: 10.1007/s10565-019-09471-x.", "ArticleIdList": ["10.1007/s10565-019-09471-x", "30941654"]}, {"Citation": "Venkatadri R., Iyer A.K.V., Kaushik V., Azad N. A novel resveratrol-salinomycin combination sensitizes ER-positive breast cancer cells to apoptosis. Pharmacol. Rep. 2017;69:788\u2013797. doi: 10.1016/j.pharep.2017.03.024.", "ArticleIdList": ["10.1016/j.pharep.2017.03.024", "28605700"]}, {"Citation": "Pan J., Shen J., Si W., Du C., Chen D., Xu L., Yao M., Fu P., Fan W. Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway. Oncotarget. 2017;8:65743\u201365758. doi: 10.18632/oncotarget.19445.", "ArticleIdList": ["10.18632/oncotarget.19445", "PMC5630368", "29029468"]}, {"Citation": "Kim Y.S., Sull J.W., Sung H.J. Suppressing effect of resveratrol on the migration and invasion of human metastatic lung and cervical cancer cells. Mol. Biol. Rep. 2012;39:8709\u20138716. doi: 10.1007/s11033-012-1728-3.", "ArticleIdList": ["10.1007/s11033-012-1728-3", "22696189"]}, {"Citation": "Zoberi I., Bradbury C.M., Curry H.A., Bisht K.S., Goswami P., Roti J.L., Gius D. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett. 2002;175:165\u2013173. doi: 10.1016/S0304-3835(01)00719-4.", "ArticleIdList": ["10.1016/S0304-3835(01)00719-4", "11741744"]}, {"Citation": "Liu Z., Li Y., She G., Zheng X., Shao L., Wang P., Pang M., Xie S., Sun Y. Resveratrol induces cervical cancer HeLa cell apoptosis through the activation and nuclear translocation promotion of FOXO3a. Pharmazie. 2020;75:250\u2013254.", "ArticleIdList": ["32539920"]}, {"Citation": "Vergara D., De Domenico S., Tinelli A., Stanca E., Del Mercato L.L., Giudetti A.M., Simeone P., Guazzelli N., Lessi M., Manzini C., et al. Anticancer effects of novel resveratrol analogues on human ovarian cancer cells. Mol. Biosyst. 2017;13:1131\u20131141. doi: 10.1039/C7MB00128B.", "ArticleIdList": ["10.1039/C7MB00128B", "28429008"]}, {"Citation": "Tang F.Y., Chen C.Y., Shyu H.W., Hong S., Chen H.M., Chiou Y.H., Lin K.H., Chou M.C., Wang L.Y., Wang Y.F. Resveratrol induces cell death and inhibits human herpesvirus 8 replication in primary effusion lymphoma cells. Chem. Biol. Interact. 2015;242:372\u2013379. doi: 10.1016/j.cbi.2015.10.025.", "ArticleIdList": ["10.1016/j.cbi.2015.10.025", "26549478"]}, {"Citation": "De Leo A., Arena G., Stecca C., Raciti M., Mattia E. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt\u2019s lymphoma cells depending on viral latency program. Mol. Cancer Res. 2011;9:1346\u20131355. doi: 10.1158/1541-7786.MCR-11-0145.", "ArticleIdList": ["10.1158/1541-7786.MCR-11-0145", "21856773"]}, {"Citation": "Geng W., Guo X., Zhang L., Ma Y., Wang L., Liu Z., Ji H., Xiong Y. Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/\u03b2-catenin signaling pathway. Biomed. Pharmacother. 2018;107:484\u2013494. doi: 10.1016/j.biopha.2018.08.003.", "ArticleIdList": ["10.1016/j.biopha.2018.08.003", "30107344"]}, {"Citation": "Sun C.Y., Hu Y., Guo T., Wang H.F., Zhang X.P., HE W.J., Tan H. Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity. Acta Pharmacol. Sin. 2006;27:1447\u20131452. doi: 10.1111/j.1745-7254.2006.00343.x.", "ArticleIdList": ["10.1111/j.1745-7254.2006.00343.x", "17049120"]}, {"Citation": "Bhardwaj A., Sethi G., Vadhan-Raj S., Bueso-Ramos C., Takada Y., Gaur U., Nair A.S., Shishodia S., Aggarwal B.B. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007;109:2293\u20132302. doi: 10.1182/blood-2006-02-003988.", "ArticleIdList": ["10.1182/blood-2006-02-003988", "17164350"]}, {"Citation": "Wu F., Cui L. Resveratrol suppresses melanoma by inhibiting NF-\u03baB/miR-221 and inducing TFG expression. Arch. Dermatol. Res. 2017;309:823\u2013831. doi: 10.1007/s00403-017-1784-6.", "ArticleIdList": ["10.1007/s00403-017-1784-6", "28936555"]}, {"Citation": "Gong C., Xia H. Resveratrol suppresses melanoma growth by promoting autophagy through inhibiting the PI3K/AKT/mTOR signaling pathway. Exp. Ther. Med. 2020;19:1878\u20131886. doi: 10.3892/etm.2019.8359.", "ArticleIdList": ["10.3892/etm.2019.8359", "PMC7027143", "32104244"]}, {"Citation": "Meng J., Liu G.J., Song J.Y., Chen L., Wang A.H., Gao X.X., Wang Z.J. Preliminary results indicate resveratrol affects proliferation and apoptosis of leukemia cells by regulating PTEN/PI3K/AKT pathway. Eur. Rev. Med. Pharmacol. Sci. 2019;23:4285\u20134292.", "ArticleIdList": ["31173300"]}, {"Citation": "Wang X.J., Li Y.H. Inhibition of human chronic myelogenous leukemia K562 cell growth following combination treatment with resveratrol and imatinib mesylate. Genet. Mol. Res. 2015;14:6413\u20136418. doi: 10.4238/2015.June.11.17.", "ArticleIdList": ["10.4238/2015.June.11.17", "26125846"]}, {"Citation": "Tomic J., McCaw L., Li Y., Hough M.R., Ben-David Y., Moffat J., Spaner D.E. Resveratrol has anti-leukemic activity associated with decreased O-GlcNAcylated proteins. Exp. Hematol. 2013;41:675\u2013686. doi: 10.1016/j.exphem.2013.04.004.", "ArticleIdList": ["10.1016/j.exphem.2013.04.004", "23597602"]}, {"Citation": "Sun Y., Wang H., Liu M., Lin F., Hua J. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1\u03b1 protein. Mol. Med. Rep. 2015;11:1975\u20131981. doi: 10.3892/mmr.2014.2913.", "ArticleIdList": ["10.3892/mmr.2014.2913", "25384583"]}, {"Citation": "Xie D., Zheng G.Z., Xie P., Zhang Q.H., Lin F.X., Chang B., Hu Q.X., Du S.X., Li X.D. Antitumor activity of resveratrol against human osteosarcoma cells: A key role of Cx43 and Wnt/\u03b2-catenin signaling pathway. Oncotarget. 2017;8:111419\u2013111432. doi: 10.18632/oncotarget.22810.", "ArticleIdList": ["10.18632/oncotarget.22810", "PMC5762332", "29340064"]}, {"Citation": "Li Y., B\u00e4ckesj\u00f6 C.M., Haldos\u00e9n L.A., Lindgren U. Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells. Eur. J. Pharmacol. 2010;609:13\u201318. doi: 10.1016/j.ejphar.2009.03.004.", "ArticleIdList": ["10.1016/j.ejphar.2009.03.004", "19285066"]}, {"Citation": "Li Y.T., Tian X.T., Wu M.L., Zheng X., Kong Q.Y., Cheng X.X., Zhu G.W., Liu J., Li H. Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells. Int. J. Mol. Sci. 2018;19:1030. doi: 10.3390/ijms19041030.", "ArticleIdList": ["10.3390/ijms19041030"]}, {"Citation": "Yu X.M., Jaskula-Sztul R., Ahmed K., Harrison A.D., Kunnimalaiyaan M., Chen H. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol. Cancer Ther. 2013;12:1276\u20131287. doi: 10.1158/1535-7163.MCT-12-0841.", "ArticleIdList": ["10.1158/1535-7163.MCT-12-0841", "PMC3707971", "23594881"]}, {"Citation": "Song Y., Chen Y., Li Y., Lyu X., Cui J., Cheng Y., Zheng T., Zhao L., Zhao G. Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling. BioMed Res. Int. 2019;2019:1321973. doi: 10.1155/2019/1321973.", "ArticleIdList": ["10.1155/2019/1321973", "PMC6500704", "31119150"]}, {"Citation": "Sareen D., van Ginkel P.R., Takach J.C., Mohiuddin A., Darjatmoko S.R., Albert D.M., Polans A.S. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. Invest. Ophthalmol. Vis. Sci. 2006;47:3708\u20133716. doi: 10.1167/iovs.06-0119.", "ArticleIdList": ["10.1167/iovs.06-0119", "16936077"]}, {"Citation": "Adhami V.M., Afaq F., Ahmad N. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. Biochem. Biophys. Res. Commun. 2001;288:579\u2013585. doi: 10.1006/bbrc.2001.5819.", "ArticleIdList": ["10.1006/bbrc.2001.5819", "11676482"]}, {"Citation": "Paller C.J., Rudek M.A., Zhou X.C., Wagner W.D., Hudson T.S., Anders N., Hammers H.J., Dowling D., King S., Antonarakis E.S., et al. A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination. Prostate. 2015;75:1518\u20131525. doi: 10.1002/pros.23024.", "ArticleIdList": ["10.1002/pros.23024", "PMC4537354", "26012728"]}, {"Citation": "Howells L.M., Berry D.P., Elliott P.J., Jacobson E.W., Hoffmann E., Hegarty B., Brown K., Steward W.P., Gescher A.J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases\u2014Safety, pharmacokinetics, and pharmacodynamics. Cancer Prev. Res. 2011;4:1419\u20131425. doi: 10.1158/1940-6207.CAPR-11-0148.", "ArticleIdList": ["10.1158/1940-6207.CAPR-11-0148", "PMC3173869", "21680702"]}, {"Citation": "Patel K.R., Brown V.A., Jones D.J., Britton R.G., Hemingway D., Miller A.S., West K.P., Booth T.D., Perloff M., Crowell J.A., et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010;70:7392\u20137399. doi: 10.1158/0008-5472.CAN-10-2027.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-2027", "PMC2948608", "20841478"]}, {"Citation": "Zhu W., Qin W., Zhang K., Rottinghaus G.E., Chen Y.C., Kliethermes B., Sauter E.R. Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr. Cancer. 2012;64:393\u2013400. doi: 10.1080/01635581.2012.654926.", "ArticleIdList": ["10.1080/01635581.2012.654926", "PMC3392022", "22332908"]}, {"Citation": "Shaito A., Posadino A.M., Younes N., Hasan H., Halabi S., Alhababi D., Al-Mohannadi A., Abdel-Rahman W.M., Eid A.H., Nasrallah G.K., et al. Potential Adverse Effects of Resveratrol: A Literature Review. Int. J. Mol. Sci. 2020;21:2084. doi: 10.3390/ijms21062084.", "ArticleIdList": ["10.3390/ijms21062084", "PMC7139620", "32197410"]}, {"Citation": "Komina O., Wesierska-Gadek J. Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells. Biochem. Pharmacol. 2008;76:1554\u20131562. doi: 10.1016/j.bcp.2008.08.002.", "ArticleIdList": ["10.1016/j.bcp.2008.08.002", "18761329"]}, {"Citation": "Lee Y.J., Lee Y.J., Im J.H., Won S.Y., Kim Y.B., Cho M.K., Nam H.S., Choi Y.J., Lee S.H. Synergistic anticancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells. Food Chem. Toxicol. 2013;52:61\u201368. doi: 10.1016/j.fct.2012.10.060.", "ArticleIdList": ["10.1016/j.fct.2012.10.060", "23146690"]}, {"Citation": "Rai G., Mishra S., Suman S., Shukla Y. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight. Phytomedicine. 2016;23:233\u2013242. doi: 10.1016/j.phymed.2015.12.020.", "ArticleIdList": ["10.1016/j.phymed.2015.12.020", "26969377"]}, {"Citation": "Zhao X.Y., Yang S., Chen Y.R., Li P.C., Dou M.M., Zhang J. Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo. PLoS ONE. 2014;9:e98925. doi: 10.1371/journal.pone.0098925.", "ArticleIdList": ["10.1371/journal.pone.0098925", "PMC4047048", "24901647"]}, {"Citation": "Al-Abd A.M., Mahmoud A.M., El-Sherbiny G.A., El-Moselhy M.A., Nofal S.M., El-Latif H.A., El-Eraky W.I., El-Shemy H.A. Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro. Cell Prolif. 2011;44:591\u2013601. doi: 10.1111/j.1365-2184.2011.00783.x.", "ArticleIdList": ["10.1111/j.1365-2184.2011.00783.x", "PMC6496784", "22011009"]}, {"Citation": "Wu S.L., Sun Z.J., Yu L., Meng K.W., Qin X.L., Pan C.E. Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J. Gastroenterol. 2004;10:3048\u20133052. doi: 10.3748/wjg.v10.i20.3048.", "ArticleIdList": ["10.3748/wjg.v10.i20.3048", "PMC4576270", "15378791"]}, {"Citation": "Dun J., Chen X., Gao H., Zhang Y., Zhang H., Zhang Y. Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis. Exp. Biol. Med. (Maywood) 2015;240:1672\u20131681. doi: 10.1177/1535370215573396.", "ArticleIdList": ["10.1177/1535370215573396", "PMC4935345", "25736303"]}, {"Citation": "Casanova F., Quarti J., da Costa D.C., Ramos C.A., da Silva J.L., Fialho E. Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest. J. Cell. Biochem. 2012;113:2586\u20132596. doi: 10.1002/jcb.24134.", "ArticleIdList": ["10.1002/jcb.24134", "22415970"]}, {"Citation": "Almeida L., Vaz-da-Silva M., Falc\u00e3o A., Soares E., Costa R., Loureiro A.L., Fernandes-Lopes C., Rocha J.F., Nunes T., Wright L., et al. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol. Nutr. Food Res. 2009;53((Suppl. S1)):S7\u2013S15. doi: 10.1002/mnfr.200800177.", "ArticleIdList": ["10.1002/mnfr.200800177", "19194969"]}, {"Citation": "Cottart C.H., Nivet-Antoine V., Laguillier-Morizot C., Beaudeux J.L. Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food Res. 2010;54:7\u201316. doi: 10.1002/mnfr.200900437.", "ArticleIdList": ["10.1002/mnfr.200900437", "20013887"]}, {"Citation": "Walle T., Hsieh F., DeLegge M.H., Oatis J.E., Jr., Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004;32:1377\u20131382. doi: 10.1124/dmd.104.000885.", "ArticleIdList": ["10.1124/dmd.104.000885", "15333514"]}, {"Citation": "Amiot M.J., Romier B., Dao T.M., Fanciullino R., Ciccolini J., Burcelin R., Pechere L., Emond C., Savouret J.F., Seree E. Optimization of trans-Resveratrol bioavailability for human therapy. Biochimie. 2013;95:1233\u20131238. doi: 10.1016/j.biochi.2013.01.008.", "ArticleIdList": ["10.1016/j.biochi.2013.01.008", "23376875"]}, {"Citation": "Das S., Lin H.S., Ho P.C., Ng K.Y. The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharmaceut. Res. 2008;25:2593\u20132600. doi: 10.1007/s11095-008-9677-1.", "ArticleIdList": ["10.1007/s11095-008-9677-1", "18629618"]}, {"Citation": "Jose S., Anju S.S., Cinu T.A., Aleykutty N.A., Thomas S., Souto E.B. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int. J. Pharmaceut. 2014;474:6\u201313. doi: 10.1016/j.ijpharm.2014.08.003.", "ArticleIdList": ["10.1016/j.ijpharm.2014.08.003", "25102112"]}, {"Citation": "Amri A., Chaumeil J.C., Sfar S., Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations? J. Control. Release. 2012;158:182\u2013193. doi: 10.1016/j.jconrel.2011.09.083.", "ArticleIdList": ["10.1016/j.jconrel.2011.09.083", "21978644"]}, {"Citation": "Singh S.K., Makadia V., Sharma S., Rashid M., Shahi S., Mishra P.R., Wahajuddin M., Gayen J.R. Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration. Drug Deliv. Transl. Res. 2017;7:395\u2013407. doi: 10.1007/s13346-017-0362-y.", "ArticleIdList": ["10.1007/s13346-017-0362-y", "28194730"]}, {"Citation": "Feng M., Zhong L.X., Zhan Z.Y., Huang Z.H., Xiong J.P. Enhanced antitumor efficacy of resveratrol-loaded nanocapsules in colon cancer cells: Physicochemical and biological characterization. Eur. Rev. Med. Pharmacol. Sci. 2017;21:375\u2013382.", "ArticleIdList": ["28165548"]}, {"Citation": "Soo E., Thakur S., Qu Z., Jambhrunkar S., Parekh H.S., Popat A. Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach. J. Colloid. Interface Sci. 2016;462:368\u2013374. doi: 10.1016/j.jcis.2015.10.022.", "ArticleIdList": ["10.1016/j.jcis.2015.10.022", "26479200"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "3"}, {"Year": "2022", "Month": "4", "Day": "18"}, {"Year": "2022", "Month": "4", "Day": "19"}, {"Year": "2022", "Month": "5", "Day": "14", "Hour": "1", "Minute": "22"}, {"Year": "2022", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["35566016", "PMC9101422", "10.3390/molecules27092665", "molecules27092665"]}}], "PubmedBookArticle": []}